Correlation between Vaginal Microecological Status and Prognosis of CIN Patients with High-Risk HPV Infection.

Many microorganisms live in the vagina of healthy women. They interact with and compete with the microenvironment in the female vagina to form a dynamic balance of the microenvironment in the female vagina. However, imbalanced vaginal microecology can lead to vaginal resistance to pathogenic microorganisms. Poor capacity can cause women to develop infections of the reproductive tract. This article analyzes the vaginal microecological status of women with high-risk HPV infection for more than 6 months and healthy women and explores the risk factors that cause long-term high-risk HPV infection for timely detection and regulation of possible vaginal microecological imbalance in women with high-risk HPV infection for more than 6 months to prevent further development of cervical lesions in such patients. This article covers women with a sexual life history who attended the gynecology department of a hospital from January 2020 to September 2021. There were 280 patients in the experimental group: positive high-risk HPV; and there were 140 patients in the control group: negative high-risk HPV test. The correlation between vaginal microecology of CIN patients and patient prognosis according to the subject's vaginal microecology test results and prognosis of various levels of cervical lesions was analyzed. The experiment proved that the detection rate of normal vaginal microecology in the experimental group was 12.14% (34/280) compared with the detection rate of 29.29% (41/140) in the control group, and there was a trend of decrease, and the difference was statistically significant (χ 2 = 17.23, P < 0.05). The detection rate of vaginal BV in the experimental group was 10.36% (29/280) compared with the detection rate of 5.0% (7/140) in the control group, and the difference was statistically significant (χ 2 = 5.19, P < 0.05). This indicates that women with high-risk HPV infections for 6 months or longer have a higher incidence of vaginal microecological imbalances than healthy individuals and aggressive vaginal microecological screening. It is necessary to carry out the program. Detect and treat possible abnormal conditions in time to prevent the further onset of the disease.

LncRNA SLC16A1-AS1 Suppresses Cell Proliferation in Cervical Squamous Cell Carcinoma (CSCC) Through the miR-194/SOCS2 Axis.

BACKGROUND: SLC16A1-AS1 has been characterized as an oncogenic long non-coding (lncRNA) in breast cancer and bladder cancer, while its role in cervical squamous cell carcinoma (CSCC) is unknown. METHODS: CSCC and non-tumor tissue samples were collected from 60 female patients, and qPCR was performed to detect the expression of SLC16A1-AS1, miR-194 and SOCS2. Luciferase reporter assay was performed to detect the interaction between SLC16A1-AS1 and miR-194. Colony formation assay was used to detect cell proliferation. RESULTS: SLC16A1-AS1 was down-regulated in CSCC and correlated with poor survival. Overexpression of SLC16A1-AS1 could inhibit the proliferation of cervical cancer cells. In addition, SLC16A1-AS1 could sponge miR-194 and increase the expression levels of SOCS2, ultimately inhibiting the proliferation of cervical cancer cells. CONCLUSION: SLC16A1-AS1 was downregulated in CSCC and suppressed cell proliferation in cervical squamous cell carcinoma (CSCC) through the miR-194/SOCS2 axis.

Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study.

OBJECTIVE: To compare 5-year disease-free survival (DFS) and overall survival (OS) rates of laparoscopic radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) for stage IB1 and tumor size <2 cm with visible or invisible tumors. METHODS: We retrospectively compared the oncological outcomes of 1,484 cervical cancer patients with IB1 and tumor size <2 cm on final pathology, who received ARH (n=899) or LRH (n=585) between January 2004 and December 2016. Patients were divided into visible tumor subgroup (ARH: n=668, LRH: n=444) and invisible tumor subgroup (ARH: n=231, LRH: n=141) according to tumor type. RESULTS: LRH and ARH showed similar 5-year DFS and OS rates (93.3% vs. 93.1%, p=0.997; 96.2% vs. 97.5%, p=0.351) in total study population. LRH was not associated with worse 5-year DFS rate (hazard ratio [HR]=0.96; 95% confidence interval [CI]=0.58-1.58; p=0.871) or OS rate (HR=1.37; 95% CI=0.65-2.89; p=0.409) by multivariable analysis. In the visible tumor subgroups, LRH and ARH showed similar 5-year DFS and OS rates (91.9% vs. 91.9%, p=0.933; 95.0% vs. 96.9%, p=0.276), and LRH was not associated with worse 5-year DFS or OS rate (p=0.804, p=0.324). In the invisible tumor subgroups, LRH and ARH also showed similar 5-year DFS and OS rates (97.3% vs. 97.1%, p=0.815; 100% vs. 99.5%, p=0.449), and LRH was not associated with worse 5-year DFS rate (p=0.723). CONCLUSIONS: Among patients with stage IB1 and tumor size <2 cm, whether the tumor is visible or not, the oncological outcomes of LRH and ARH among cervical cancer patients are comparable. This suggests that LRH may be suitable for stage IB1 and tumor size <2 cm with visible or invisible tumors. TRIAL REGISTRATION: International Clinical Trials Registry Platform Identifier: CHiCTR180017778.

Recognition and selective extraction of poly-γ-glutamic acid based on molecular imprinting technology.

Poly-γ-glutamic acid (γ-PGA) is one of the few bacterial polymers in nature with high added value of biodegradability. Especially, the traditional method of extracting γ-PGA is organic solvent extraction, etc., which has the disadvantages of low extraction rate and serious environmental pollution. With the expansion of γ-PGA industrial fermentation, an efficient and environmentally friendly method is required to be adopted. In this contribution, we report a novel method of separation of γ-PGA from fermentation broth based on molecular imprinting technology. The molecular imprinted polymer (MIP) was synthesized from chitosan (CS) and glutaraldehyde in the presence of γ-PGA. A nonimprinted polymer (NIP) was also synthesized by the same procedure in the absence of γ-PGA. The chemical structures and morphological structures of both MIP and NIP were examined by FTIR spectroscopy and scanning electron microscopy. The adsorption isotherms showed that the maximum adsorption capacity of MIP was 137.85 mg/g. The maximum adsorption capacity in the adsorption of NIP was 68.92 mg/g, which indicates that MIP shows specific selectivity for γ-PGA. A high saturated absorption capacity (Qmax=140.90 mg/g) was calculated from Freundlich isotherm equation. The imprinting factor of MIP was 4.76, indicating that MIP possess good recognition ability and selectivity for γ-PGA. The adsorption capacity decreased slightly (17.0%), which suggests the satisfactory reusability of γ-PGA after 5 cycles of reuse. Our study indicates that molecularly imprinted polymers present development prospects in the effective and selective separation of γ-PGA from fermentation broth compared with organic solvent precipitation.

The Anti-Proliferative Effect of Flavonoid Nanoparticles on the Human Ovarian Cancer Cell Line SK0V3.

To investigate the anti-proliferative effect of flavonoid nanoparticles on the human ovarian cancer cell line SKOV3. Ten nude mice were intraperitoneally inoculated with the human ovarian cancer SKOV3 cell mixture. The treatment group received tail vein injections with 1.25 mg/kg of flavonol, once every 3 days, 0.2 mL each time, for a total of 12 times. The control group was a tumor model that was injected with 50 mL/L glucose solution; it was observed in Lacquerin Group as the Laccase Nanoparticle Group. Tumor quality was recorded after treatment. The morphology of tumor cells in the two groups was observed by fluorescence microscopy. MTS was used to measure the value of tumor cells in the two groups after administration. Apoptosis of SKOV3 cells was detected by flow cytometry using a tumor cell suspension. The MTT results showed a decreased growth rate of SKOV3 cells with an increase in the mass concentration of flavonoid nanoparticles. The nude mice in the control group had scattered cauliflower-like tumor nodules. The treatment group only showed very small granular tumor nodules. The tumor mass within the treatment group was comparable (P > 0.05), but was lower than that in the control group (P < 0.05). The morphology of the tumor cells in the treatment group became longer and thinner and showed a slender spindle shape. Some high-temperature treated cells even appeared star-shaped, and the cell bodies were significantly broadened. Flow cytometry results showed significantly increased apoptosis of the SKOV3 cells after treatment with flavonoid nanoparticles. The MTS results showed a significantly slowed proliferation rate of SKOV3 cells after two days of administering flavonoid nanoparticles (P < 0.05). Flavonoid nanoparticles were nontoxic, and decreased cell proliferation of and promoted apoptosis in an ovarian cancer cell line.

Preparation of Mesoporous Mn-Ce-Ti-O Aerogels by a One-Pot Sol-Gel Method for Selective Catalytic Reduction of NO with NH3.

Novel Mn-Ce-Ti-O composite aerogels with large mesopore size were prepared via a one-pot sol-gel method by using propylene oxide as a network gel inducer and ethyl acetoacetate as a complexing agent. The effect of calcination temperature (400, 500, 600, and 700 °C) on the NH3-selective catalytic reduction (SCR) performance of the obtained Mn-Ce-Ti-O composite aerogels was investigated. The results show that the Mn-Ce-Ti-O catalyst calcined at 600 °C exhibits the highest NH3-SCR activity and lowest apparent activation energy due to its most abundant Lewis acid sites and best reducibility. The NO conversion of the MCTO-600 catalyst maintains 100% at 200 °C in the presence of 100 ppm SO2, showing the superior resistance to SO2 poisoning as compared with the MnOx-CeO2-TiO2 catalysts reported the literature. This should be mainly attributed to its large mesopore sizes with an average pore size of 32 nm and abundant Lewis acid sites. The former fact facilitates the decomposition of NH4HSO4, and the latter fact reduces vapor pressure of NH3. The NH3-SCR process on the MCTO-600 catalyst follows both the Eley-Rideal (E-R) mechanism and the Langmuir-Hinshelwood (L-H) mechanism.

Insights into the promotion role of phosphorus doping on carbon as a metal-free catalyst for low-temperature selective catalytic reduction of NO with NH3.

The catalytic reduction of NO with NH3 (NH3-SCR) on phosphorus-doped carbon aerogels (P-CAs) was studied in the temperature range of 100-200 °C. The P-CAs were prepared by a one-pot sol-gel method by using phosphoric acid as a phosphorus source followed by carbonization at 600-900 °C. A correlation between catalytic activity and surface P content is observed. The P-CA-800vac sample obtained via carbonization at 800 °C and vacuum treatment at 380 °C shows the highest NO conversion of 45.6-76.8% at 100-200 °C under a gas hourly space velocity of 500 h-1 for the inlet gas mixture of 500 ppm NO, 500 ppm NH3 and 5.0 vol% O2. The coexistence of NH3 and O2 is essential for the high conversion of NO on the P-CA carbon catalysts, which can decrease the spillover of NO2 and N2O. The main Brønsted acid sites derived from P-doping and contributed by the C-OH group at edges of carbon sheets are beneficial for NH3 adsorption. In addition, the C3-P[double bond, length as m-dash]O configuration seems to have the most active sites for favorable adsorption and dissociation of O2 and facilitates the formation of NO2. Therefore, the simultaneous presence of acidic groups for NH3 adsorption and the C3-P[double bond, length as m-dash]O active sites for NO2 generation due to the activation of O2 molecules is likely responsible for the significant increase in the NH3-SCR activity over the P-CAs. The transformation of C3-P[double bond, length as m-dash]O to C-O-P functional groups after the reaction is found, which could be assigned to the oxidation of C3-P[double bond, length as m-dash]O by the dissociated O*, resulting in an apparent decrease of catalytic activity for P-CAs. The C-O-P based functional groups are also active in the NH3-SCR reaction.

lncRNA HAND2-AS1 inhibits cancer cell proliferation, migration and invasion by downregulating ROCK1 in HPV-positive and negative cervical squamous cell carcinoma.

Long non-coding (lnc)RNA HAND2 antisense RNA 1 (HAND2-AS1) exhibited tumor suppression activity in different types of cancer. However, its role in cervical squamous cell carcinoma (CSCC), which is frequently diagnosed among females, has not been elucidated. The current study revealed that lncRNA HAND2-AS1 was downregulated, while Rho-associated protein kinase 1 (ROCK1) was upregulated in serum of human papillomavirus (HPV)-positive and -negative patients with CSCC compared with healthy controls. Correlation analysis revealed that the expression levels of lncRNA HAND2-AS1 were negatively correlated with the expression levels of ROCK1 in HPV-positive and -negative patients with CSCC but not in healthy controls. Downregulation of lncRNA HAND2-AS1 distinguished patients with CSCC from healthy controls. Additionally, lncRNA HAND2-AS1 overexpression led to reduced expression levels of ROCK1 in HPV-positive and -negative human CSCC cell lines but not in normal cervical cell lines. ROCK1 overexpression did not significantly affect the expression of lncRNA HAND2-AS1 in all the cell lines investigated. lncRNA HAND2-AS1 overexpression inhibited, while ROCK1 overexpression promoted the proliferation, migration and invasion of HPV-positive and -negative human CSCC cell lines but not normal cervical cell lines. ROCK1 overexpression attenuated the effects of lncRNA HAND2-AS1 overexpression on cancer cell proliferation, migration and invasion. lncRNA HAND2-AS1 may inhibit cancer cell proliferation, migration and invasion by downregulating ROCK1 in HPV-positive and -negative CSCC.

Survival After Abdominal Q-M Type B versus C2 Radical Hysterectomy for Early-Stage Cervical Cancer.

PURPOSE: To evaluate the survival outcomes of abdominal Q-M type B and type C2 radical hysterectomy (RH) for early-stage (IA1 (lymphovascular invasion)-IIA2) cervical cancer. PATIENTS AND METHODS: Based on this multicenter, retrospective cohort study on the clinical diagnosis and treatment for cervical cancer in China (Four C), the survival outcomes of abdominal type B and type C2 RH for early-stage cervical cancer were compared under real-world and matched cohort study conditions. RESULTS: In total, 46,313 cases were included in the Four C database, among whom 20,018 underwent abdominal type B or type C2 RH. In the real-world study, no differences were found in the 5-year overall survival (OS) between the type B group (n=15,471) and type C2 group (n=4547), but the 5-year disease-free survival (DFS) was lower in the type C2 group (82.1 vs 84.8%, hazard ratio: 1.144). Based on the inclusion criteria, 9135 cases were included and the type C2 group (n=1818) was found to have a lower 5-year OS and DFS (OS: 89.5 vs 92.0%, hazard ratio: 1.393; DFS: 84.3 vs 87.4%, hazard ratio: 1.342). Subsequently, 1799 cases from each group were matched and the type C2 group had a lower 5-year DFS (84.6 vs 88.4%, hazard ratio: 1.332). Upon further analysis of the subgroups, the type C2 group had a lower 5-year OS and DFS (OS: 90.3 vs 93.8%, hazard ratio: 1.522; DFS: 85.2 vs 89.4%, hazard ratio: 1.439). CONCLUSION: Q-M type B RH could be used for the treatment of stage IA1 (lymphovascular invasion)-IIA2 cervical cancer.

MicroRNA­139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.

The current study investigated the expression and functional roles of microRNA­139 (miR­139) on human epithelial ovarian cancer (EOC). Reverse transcription­quantitative polymerase chain reaction (RT­qPCR) was performed to measure miR­139 expression in EOC tissues and cell lines. The effects of miR­139 on EOC cell proliferation, migration and invasion were assessed using MTT, cell migration and invasion assays, respectively. Subsequently, the molecular mechanism underlying the tumor suppressive roles of miR­139 on EOC was determined by bioinformatics analysis, RT­qPCR, western blotting and the luciferase reporter assay. According to the results, it was identified that miR­139 was significantly downregulated in EOC tissues and cell lines. In addition, restoration of miR­139 suppressed tumor cell proliferation, migration and invasion in EOC. Furthermore, hepatoma­derived growth factor (HDGF) was identified as a target of miR­139 in EOC. Upregulation of HDGF could rescue the inhibitory effects exerted by miR­139 overexpression on EOC cell proliferation, migration and invasion. Collectively, the results indicated that miR­139 was downregulated in EOC, and acted as a tumor suppressor by directly targeting HDGF. To the best of our knowledge, this was the first study to identify that miR­139 contributes to the growth and metastasis of EOC.